v3.19.3.a.u2
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating activities    
Net loss for the period $ (8,473,278) $ (7,127,966)
Adjustment for items not affecting cash:    
Depreciation 78,665 50,190
Amortization 207,943 209,682
Interest expense 146,144 129,933
Share based compensation expense 1,373,195 1,226,374
Accretion expense 0 2,421,060
Fair value adjustment 0 (337,923)
Gain on mark to market re-evaluation 0 (2,048,697)
Allowance for doubtful accounts 167,500 6,001
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities (6,499,831) (5,471,346)
Changes in non-cash working capital items:    
Accounts receivable 1,057,564 (1,314,380)
Prepaid expenses and other receivables (374,802) (1,398,301)
Due from related parties (809) 908
Inventories (1,029,739) (98,163)
Accounts payable (424,805) 669,779
Accrued liabilities (465,084) (429,935)
Customer advances 0 (800)
Deferred revenue 209,974 162,473
Net cash (used in) operating activities (7,527,532) (7,879,765)
Investing activities    
Acquisition of equipment (95,730) (26,071)
Net cash (used in) investing activities (95,730) (26,071)
Financing activities    
Proceeds from convertible loans 9,070,000 7,826,633
Repayment of demand notes principal 0 (50,000)
Repayment of demand notes interest 0 (2,975)
Proceeds from short term loan 500,000 0
Repayment of short term loan (500,000) 0
Net cash provided by financing activities 9,070,000 7,773,658
Net increase (decrease) in cash and cash equivalents for the period 1,446,738 (132,178)
Cash and cash equivalents, beginning of period 446,779 507,311
Cash and cash equivalents, end of period $ 1,893,517 $ 375,133

Source